Researchers hope that identifying the genomic alterations specific to transformed small cell lung cancer (SCLC) can help ...

Clinicians and scientists from RWJBarnabas Health and Rutgers Cancer Institute will share new findings and lead discussions ...

Foundation Medicine shares details on the 15+ abstracts the company and its collaborators will present at the 2025 ASCO® Annual Meeting.

Samuraciclib improved progression-free survival in HR+ advanced breast cancer patients without TP53 mutations or liver ...

With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment ...

Recent phase 2 data support combination treatment with samuraciclib for those with HR+ advanced breast cancer following prior ...

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new ...

Dr. Samuel Rosner, a thoracic oncologist at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, said a growing number of people, particularly women under 65, are ...